海外の治験の状況「1」での検索結果
1993件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Authorised
- Phase II study in patients suffering from metastatic breast cancer Her2neg, The Line, randomized (1:1) with two arms.
- patients wiyh metastatic breast cancer her2 negative first line treatment MedDRA version: 14.1 Level: SOC Classification code 10029104 Term: Neoplasms benign, malignant and unspecified (incl cysts and polyps) System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Italy
- 2012-07-23
Authorised
- Individualised choise of 1.line chemotherapy of metastatic colo-rectal cancer. Can the blood test: TIMP-1 help the doctor to choose the best chemotherapy for the individual patient?
- Metastatic colon or rectal cancer MedDRA version: 14.1 Level: PT Classification code 10027457 Term: Metastases to liver System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 14.1 Level: PT Classification code 10010035 Term: Colorectal cancer stage IV System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Denmark
- 2012-04-18
Authorised
- A randomised, double-blind, placebo-controlled Phase II study to target the type I IFN receptor by administrating Anifrolumab in patients with rheumatoid arthritis who have a high interferon signature (TarIFNiRA)
- High IFN siganture in patients with rheumatoid arthritis MedDRA version: 20.0 Level: PT Classification code 10039073 Term: Rheumatoid arthritis System Organ Class: 10028395 - Musculoskeletal and connective tissue disorders ;Therapeutic area: Diseases [C] - Immune System Diseases [C20]
- Austria, Italy, Switzerland
- 2017-08-17
Authorised
- Effect of insulin glulisine compared to insulin aspart and insulin lispro when administered by Continuous Subcutaneous Insulin Infusion (CSII) on specific pump parameters in patient with Type 1 Diabetes Mellitus - Pump Study
- Type I Diabetes Mellitus MedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus
- Austria, France, Hungary, Italy, Netherlands, Spain, Sweden, United Kingdom
- 2007-10-04
Authorised
- A Phase 2/3, Randomized, Double-Blind, Multicenter, Multinational, 4-Arm, Controlled, Dose-Ranging Study to Evaluate Efficacy and Safety of Teplizumab (MGA031), a Humanized, FcR Non-Binding, Anti-CD3 Monoclonal Antibody, in Children and Adults with Recent-Onset Type 1 Diabetes Mellitus - Protégé
- Recent-onset type I diabetes mellitus (T1DM) MedDRA version: 9.0 Level: LLT Classification code 10045228
- Estonia, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
- 2006-10-19
Authorised
- A study of AZD4547 in patients with tumours having high number of copies of the FGFR1 or FGFR2 gene.
- Advanced Breast Cancer Advanced Lung Cancer Advanced Upper gastrointestinal cancer
- United Kingdom
- 2011-11-22
Authorised
- Randomized, open label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with hormone therapy driven by circulating DNA ESR1 mutation monitoring in estrogen receptor-positive, HER2-negative metastatic breast cancer patients PADA-1 (PAlbociclib and circulating tumor DNA for ESR1 mutation detection) - PADA-1
- HER-2 negative metastatic breast cancer;Therapeutic area: Diseases [C] - Cancer [C04]
- France
- 2017-02-02
Authorised
- A Phase III, Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group Study of the Safety and Efficacy of the Intravenous and Oral Formulations of the Neurokinin-1 Receptor Antagonist, Casopitant (GW679769) in Combination with Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Induced By Moderately Emetogenic Chemotherapy
- Chemotherapy induced nausea and vomiting (CINV) due to Moderately Emetogenic Chemotherapy (MEC)
- Czech Republic, Denmark, Estonia, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Spain, United Kingdom
- 2006-04-28
Authorised
- METFORMIN VS PLACEBO IN NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS: A RANDOMIZED CLINICAL TRIAL - ND
- NEWLY DIAGNOSED TYPE 1 DIABETES MELLITUS br>MedDRA version: 9.1 Level: LLT Classification code 10045228 Term: Type I diabetes mellitus
- Italy
- 2008-09-18
Authorised
- A MULTICENTER OPEN LABEL PHASE II STUDY OF THE EFFICACY AND SAFETY OF AMG 479, A FULLY HUMAN MONOCLONAL ANTIBODY AGAINST INSULIN-LIKE GROWTH FACTOR TYPE 1 RECEPTOR (IGF-1R) AS SECOND LINE THERAPY IN PATIENTS WITH RECURRENT PLATINUMSENSITIVE OVARIAN CANCER
- Recurrent Platinum-sensitive ovarian cancer MedDRA version: 9.1 Level: LLT Classification code 10033128 Term: Ovarian cancer
- France, Germany, Ireland, Spain
- 2008-08-22